Venetoclax combination with Cladribine, idarubicin, Cytarabine for relapsed T-Cell acute lymphoblastic leukemia/lymphoblastic lymphoma treatment: A case report and literature review

Acute lymphoblastic leukemia (ALL) represents only 20 % of adult acute leukemias, while Lymphoblastic lymphoma is even rarer, accounting for 2 % of adult non-Hodgkin lymphomas. T-acute lymphoblastic leukemia (T-ALL) and T-lymphoblastic lymphoma (T-LBL) are neoplasms characterized by the presence of...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Alaa Eldein Yahia, Ibrahim Motabi, Abdullah A. Alsakkaf, Kamal Alzahrani, Laila M. Alsuhaibani, Bilal Albtoosh, Abdullah Khaled AlBathi, Abdullah M. Alrajhi
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2025-01-01
Serija:	Leukemia Research Reports
Teme:	Venetoclax Cladribine Idarubicin Cytarabine T-cell acute lymphoblastic lymphoma
Online dostop:	http://www.sciencedirect.com/science/article/pii/S2213048925000081
Oznake:	Označite Brez oznak, prvi označite!